By Heather Landi
Tia, a startup building what it calls a "modern medical home for women," inked its second major partnership with a U.S. hospital system to expand access to women's health. The startup on Monday opened its flagship San Francisco clinic, the first in the Bay Area, at the historic 1500 Mission building.
read more
By Heather Landi
Telehealth startup Cerebral said Wednesday it would stop writing prescriptions for Adderall, Ritalin and other controlled substances to new ADHD patients. The problems at Cerebral intensified Wednesday as Insider reported that the Drug Enforcement Agency (DEA) is investigating the company.
read more
By Heather Landi
Telehealth giant Teladoc warned of a weak sales outlook for 2022 and some analysts are now questioning the company's long-term growth prospects as it faces competitive headwinds.
read more
By Paige Minemyer
Mental health concerns are on the rise across the board, and especially among Blacks, seniors, young adults and LGBTQIA people, a new survey finds.
read more
By Paige Minemyer
The health insurance giant's coverage policy aligns with Medicare's recent coverage determination, with the insurer saying it will cover the drug for people in clinical trials and will require prior authorization.
read more
By Robert King
A major new report from an HHS watchdog on prior authorization denials in Medicare Advantage sparked an urgent effort to get Congress to act on the issue.
read more
By Heather Landi
Hello Heart, a startup that helps people manage their heart health at home using their smartphones, is seeing a spike in demand among employers for digital cardiovascular solutions. The startup banked a $70 million financing round to help fuel its growth.
read more
By Paige Minemyer
Cigna is launching a new provider consult service that aims to improve outcomes for patients with cancer.
read more
By Paige Minemyer
The healthcare giant also beat the Street on revenue, posting $76.8 billion for the first quarter.
read more
Sponsored By: Vida Health
Can diabetes truly be reversed? The journey to diabetes remission is not “one size fits all”. By taking a holistic and realistic approach, we see our members achieve a 33% greater reduction in A1C when we treat them for diabetes and depression simultaneously. Combatting the myths of diabetes reversal will serve to improve outcomes of diabetes treatment and develop comprehensive support for individuals with diabetes. Download The 5 Myths of Diabetes Reversal to learn more.
Sponsored by: Lumeon
Download the Future of Digital Transformation Report to discover 4 key action points to transform the patient and care team experience.